CPhI China 2008 • Exhibition
China is a dynamic emerging market for pharmaceuticals. The market maintains an annual growth of 18% and hopefully it will become the 5th biggest pharmaceutical market in 2010. As global API production is being transferred toward China, the need of custom manufacturing is expanding. While keep the traditional advantage of Chinese chemical API, will increase the market share of generic API in global market.
Step on international center stage; Build more business relations. Come and join us!
CPhI China 2008 Data Analysis (estimated):
Exhibitors: more than 1600 exhibitors. 160 overseas companies from 20 countries and regions.
Famous exhibitors:
a. Global corporations such as Rodia, Siegfried, Alchem, Dragenopharm, Flavine, United Laboratories, Livzon, Huber, Rohm & Hass，Chemwerth, Leo Chemical, etc.
b. Leading local Chinese corporations such as A.H.A International Co., Shijiazhuang Pharma. Group, North China PharmaGroup, Harbin Pharma Group, Northeast Pharma Group, Shanghai Pharma Group, FORSUN Pharma Group, Lukang Pharma Co., Shandong Xinhua Pharma Co., etc.
c. Industry outstanding enterprises including Hisun Pharma Co., Zhejiang Huahai Pharma Co., Xiamen Mchem Pharma Group, Zhejiang Hisoar Pharma Co., Zhejiang Jiuzhou Pharma Co., Sinochem Ningbo Ltd., Sinochem Jiangsu Ltd., Desano, Zhejiang Hengdian Imp. & Exp, Apeloa, etc.
Professional visitors: 29,200 person-time, among which overseas visitors 8,700 person-time, accounting for 30%
Job title of professional visitors (top 3): Department Manager, CEO, Purchase Manager
